• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YU Lingqun,GAO Weiping,SHI Mingqian,XIN Xin,WANG Mengyuan,CAO Guiyun,YANG Ying.Study on the mechanism of Shexiang Xintongning against neointimal hyperplasia after vascular injury in rats based on Rho/Rock pathway[J].Journal Of Pharmaceutical Research,2024,43(3):232-235[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2760times   Download 3154次 QR Code for this article
Scan with your phone!
基于Rho/Rock通路研究麝香心痛宁抗大鼠血管损伤后内膜增生的机制研究
于凌群1,高伟萍1,史明仟1,辛新1,王萌媛1,曹桂云2,杨莹1
Font:Larger+|Default|Smaller-
(1.山东中医药大学,山东 济南 250355;2.山东宏济堂制药集团股份有限公司,山东 济南 250103)
摘要:
目的 观察麝香心痛宁抗大鼠血管损伤后内膜增生的作用及可能的作用机制。 方法 30只SD大鼠随机分为假手术组、模型对照组和麝香心痛宁组。采用球囊损伤法制备大鼠腹主动脉血管损伤模型,造模后灌胃给予大鼠麝香心痛宁片(200 mg•kg-1),14 d后将大鼠处死,取其血清及腹主动脉,主动脉血管进行HE染色,检测血清 SOD、MDA、MCP-1及GSH-PX 含量,ELISA法检测大鼠血管组织NO、ET-1、VEGF和IL-1β的含量,实时荧光定量PCR和 Western blotting检测Rho、Rock1和Rock2 mRNA 和蛋白的表达。结果 与假手术组比较,模型对照组大鼠腹主动脉血管组织内膜增生,腹主动脉血管部位弹力变弱且管壁增厚。麝香心痛宁治疗后血管内膜损伤程度减轻。与模型对照组相比,麝香心痛宁组大鼠血清 SOD、GSH-Px 活性升高,MCP-1、MDA 活性降低(P<0.05);血管组织NO含量升高,ET-1、VEGF和IL-1β含量降低(P<0.05);Rho/Rock通路相关因子Rock1、Rock2、Rho的表达降低(P<0.05)。结论 麝香心痛宁可抑制血管损伤后内膜增生,其作用机制可能与抑制Rho/Rock信号通路有关。
关键词:  Rho/Rock通路  麝香心痛宁  内膜增生  动脉球囊损伤
DOI:10.13506/j.cnki.jpr.2024.03.005
基金项目:山东省中医药科技项目(No.M-2022146);国家级大学生创新创业训练计划项目(No.202110441016)
Publication Date:March 25, 2024
Study on the mechanism of Shexiang Xintongning against neointimal hyperplasia after vascular injury in rats based on Rho/Rock pathway
YU Lingqun1,GAO Weiping1,SHI Mingqian1,XIN Xin1,WANG Mengyuan1,CAO Guiyun2,YANG Ying1
(1.Shandong University of Traditional Chinese Medicine, Jinan 250355, China;2.Shandong Hongjitang Pharmaceutical Group Co.,Ltd., Jinan 250103, China)
Abstract:
Objective To observe the effect of Shexiang Xintongning(SXN) on intimal hyperplasia after vascular injury in rats and explore possible mechanisms of action.Methods 30 Sprague-Dawley rats were randomly divided into control,model,and SXN groups.The rat model of abdominal aortic vascular injury was prepared by balloon injury method. After the model was constructed, SXN (200 mg•kg-1) was given by intragastric administration. After administrated with drugs for 14 days, and the serum and abdominal aortic vascular tissues were collected, and the aortic vessels were stained with HE, the contents of SOD, MDA, MCP-1 and GSH-PX in serum were detected, the contents of NO, ET-1, VEGF and IL-1β in rat vascular tissues were detected by ELISA, the mRNA and protein expressions of Rho, Rock1 and Rock2 were detected by real-time qPCR and Western blotting.Results Compared with control group, the intima hyperplasia of abdominal aorta in model group was increased, the elasticity of some parts of abdominal aorta was weakened and the tube wall was thickened. The injury degree of vascular intima was reduced after SXN treatment. Compared with model group, the activities of SOD and GSH-Px in serum of SXN group were increased, while the activities of MCP-1 and MDA were decreased (P<0.05). The contents of NO in vascular tissue were increased, and the contents of ET-1, VEGF and IL-1β were decreased (P<0.05). The expressions of Rho/Rock pathway-related factors Rock1, Rock2 and Rho were decreased (P<0.05).Conclusion SXN reduces intimal injury in rats with vascular injury, which may be related to its inhibition of Rho/Rock signaling pathway.
Key words:  Rho/Rock pathway  Shexiang Xintongning  Intimal hyperplasia Arterial balloon injury
Today's Visits:468    Total Visits:2383167
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.